Connection

Nigel Temperton to Neutralization Tests

This is a "connection" page, showing publications Nigel Temperton has written about Neutralization Tests.
Connection Strength

0.232
  1. Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays. Viruses. 2020 09 10; 12(9).
    View in: PubMed
    Score: 0.080
  2. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis. 2005 Mar; 11(3):411-6.
    View in: PubMed
    Score: 0.027
  3. Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses. Viruses. 2021 08 10; 13(8).
    View in: PubMed
    Score: 0.021
  4. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Cell. 2021 08 05; 184(16):4220-4236.e13.
    View in: PubMed
    Score: 0.021
  5. Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies. Viruses. 2021 04 20; 13(4).
    View in: PubMed
    Score: 0.021
  6. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature. 2021 05; 593(7857):136-141.
    View in: PubMed
    Score: 0.021
  7. Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020. Euro Surveill. 2020 10; 25(42).
    View in: PubMed
    Score: 0.020
  8. Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant. Cell Rep Med. 2020 09 22; 1(6):100099.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.